The Securities and Exchange Commission (SEC) on Thursday charged the former chief financial officer of biopharmaceutical company Immunomedics (IMMU) and his former romantic partner with insider trading.

Intelligence, benchmarking, and certification for risk and compliance leaders, from the institution setting the standard since 1922.
The Securities and Exchange Commission (SEC) on Thursday charged the former chief financial officer of biopharmaceutical company Immunomedics (IMMU) and his former romantic partner with insider trading.
Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,... More by Jaclyn Jaeger
We'll send a verification code to %EMAIL%.